Origin of Estrogen and Regulation of Its Formation in Postmenopausal Women

  • M. Linette Casey
  • Paul C. MacDonald
Part of the Clinical Perspectives in Obstetrics and Gynecology book series (CPOG)

Abstract

In premenopausal, ovulatory women, estrogen arises by two mechanisms. It is believed that the biologically more important of these is the synthesis of 17β-estradiol in the developing follicle. This obtains since 17β-estradiol is a more potent estrogen than that produced by the second mechanism, i.e., the extraglandular formation of estrone from circulating andro-stenedione. The rate of extraglandular estrone formation does not vary appreciably during the ovarian cycle (Fig. l-l).1 On average, about 3 mg of androstenedione are produced each day in young women and 1.5% of plasma androstenedione is aromatized (the process of converting androgen to estrogen) to estrone in extraglandular tissues.1–4 Thus, approximately 45 μg of estrone arise by this mechanism. At the extremes of the ovarian cycle, this amount of estrone may constitute 50% or more of the total estrogen produced in young women.1 The rate of secretion of 17β-estradiol by the ovary, however, varies widely during the ovarian cycle (Fig. 1-1). It is estimated that the rate of secretion of 17β-estradiol varies from 20–40 μg/day early and late in the cycle to as much as 600–1000 μg/dayjust prior to the midcycle LH (luteinizing hormone) surge and ovulation.1

Keywords

Obesity Estrogen Testosterone Androgen Estradiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Siiteri PK, MacDonald PC. Role of extraglandular estrogen in human endocrinology. In: Greep RO, Astwood EB, eds. Handbook of physiology. Washington DC: American Physiology Society, Section 7: Endocrinology, 1963:615–629.Google Scholar
  2. 2.
    VandeWiele RL, MacDonald PC, Gurpide E, et al. Studies on the secretion and interconversion of the androgens. Rec Prog Horm Res. 1963; 19:275–309.PubMedGoogle Scholar
  3. 3.
    MacDonald PC, VandeWiele RL., Lieberman S. Precursors of the urinary 11-desoxy-17-ketoste-roids of ovarian origin. Am J Obstet Gynecol. 1963; 86:1–10.Google Scholar
  4. 4.
    MacDonald PC, Grodin JM, Siiteri PC. Dynamics of androgen and oestrogen secretion. In: Baird D, ed. Gonadal steroid secretion. Edinburgh: Ciba Foundation Symposium, 1971:158–174.Google Scholar
  5. 5.
    Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973; 36:207–214.PubMedCrossRefGoogle Scholar
  6. 6.
    Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol. 1971; 111:778–781.PubMedGoogle Scholar
  7. 7.
    Judd HL, Judd GE, Lucas WE. Endocrine function of the postmenopausal ovary: Concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab. 1974; 39:1020–1024.PubMedCrossRefGoogle Scholar
  8. 8.
    MacDonald PC, Edman CD, Kerber IJ, et al. Plasma precursors of estrogen: III. Conversion of plasma dehydroisoandrosterone to estrogen in young, nonpregnant women. Gynecol Invest. 1976; 7:165–175.PubMedCrossRefGoogle Scholar
  9. 9.
    MacDonald PC, Madden JD, Brenner PF, et al. Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab. 1979; 49:905–916.PubMedCrossRefGoogle Scholar
  10. 10.
    Gurpide E. Hormones and gynecologic cancer. Cancer. 1976; 38(suppl l):503–508.PubMedCrossRefGoogle Scholar
  11. 11.
    Longcope C, Layne DS, Tait JF. Metabolic clearance rates and interconversions of estrone and 17β-estradiol in normal males and females. J Clin Invest. 1968; 47:93–106.PubMedCrossRefGoogle Scholar
  12. 12.
    Schindler AE, Ebert A, Friedrich E. Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab. 1972; 35:627–630.PubMedCrossRefGoogle Scholar
  13. 13.
    Bolt HM, Gobel P. Formation of estrogens from androgens by human subcutaneous adipose tissue in vitro. Horm Metab Res. 1972; 4:312–313.PubMedCrossRefGoogle Scholar
  14. 14.
    Nimrod A, Ryan KJ. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab. 1975; 40:367–372.PubMedCrossRefGoogle Scholar
  15. 15.
    Perel E, Killinger DW. The interconversion and aromatization of androgens by human adipose tissue. J Steroid Biochem. 1979; 10:623–627.PubMedCrossRefGoogle Scholar
  16. 16.
    Schweikert HU, Milewich L, Wilson JD. Aromatization of androstenedione by cultured human fibroblasts. J Clin Endocrinol Metab. 1976; 43:785–795.PubMedCrossRefGoogle Scholar
  17. 17.
    Schweikert HU, Milewich L, Wilson JD. Aro-matization of androstenedione by isolated human hairs. J Clin Endocrinol Metab. 1975; 40:413–417.PubMedCrossRefGoogle Scholar
  18. 18.
    Naftolin F, Ryan K, Petro Z. Aromatization of androstenedione by the diencephalon. J Clin Endocrinol Metab. 1971; 33:368–370.PubMedCrossRefGoogle Scholar
  19. 19.
    Frisch RE, Canick JA, Tulchinsky D. Human fatty marrow aromatizes androgen to estrogen. J Clin Endocrinol Metab. 1980; 51:394–396.PubMedCrossRefGoogle Scholar
  20. 20.
    Longcope C, Pratt JH, Schneider SH, et al. Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab. 1978; 46:146–152.PubMedCrossRefGoogle Scholar
  21. 21.
    Perel E, Wilkins D, Killinger DW. The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J Steroid Biochem. 1980; 13:89–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Schweikert HU. Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin. Horm Metab Res. 1979; 11:635–640.PubMedCrossRefGoogle Scholar
  23. 23.
    Maclndoe JH. Estradiol formation from testosterone by continuously cultured human breast cancer cells. J Clin Endocrinol Metab. 1979; 49:272–277.CrossRefGoogle Scholar
  24. 24.
    MacDonald PC, Grodin JM, Edman CD, et al. Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol. 1976; 47:644–650.PubMedGoogle Scholar
  25. 25.
    Aiman EJ, Nalick RH, Jacobs A, et al. The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas. Obstet Gynecol. 1977; 49:695–704.PubMedGoogle Scholar
  26. 26.
    Aiman EJ, Edman CD, Worley RJ, et al. Androgen and estrogen formation in women with ovarian hyperthecosis. Obstet Gynecol. 1978; 51:1–9.PubMedGoogle Scholar
  27. 27.
    Klyde BJ, Hirsch J. Increased cellular proliferation in adipose tissue of adult rats fed a high fat diet. J Lipid Res. 1979; 20:705–715.PubMedGoogle Scholar
  28. 28.
    Klyde BJ, Hirsch J. Isotopic labeling of DNA in rat adipose tissue for proliferating cells associated with mature adipocytes. J Lipid Res. 1979; 20:691–704.PubMedGoogle Scholar
  29. 29.
    Siiteri PK, Williams JE, Takaki NK. Steroid abnormalities in endometrial and breast carcinoma: A unifying hypothesis. J Steroid Biochem. 1976; 7:897–903.PubMedCrossRefGoogle Scholar
  30. 30.
    Ackerman GE, Smith ME, Mendelson CR, et al. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab. 1981; 412–417.Google Scholar
  31. 31.
    Mendelson CR, Cleland WH, Smith ME, et al. Regulation of aromatase activity of stromal cells derived from human adipose tissue. Endocrinology. 1982; 1077–1085.Google Scholar
  32. 32.
    Hemsell DL, Grodin JM, Brenner PF, et al. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974; 38:476–479.PubMedCrossRefGoogle Scholar
  33. 33.
    MacDonald PC, Edman CD, Hemsell DL, et al. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 1978; 130:448–455.PubMedGoogle Scholar
  34. 34.
    Wynder EL, Fisher GC, Mantel N. An epidemiological investigation of cancer of the endometrium. Cancer. 1966; 19:489–520.PubMedCrossRefGoogle Scholar
  35. 35.
    Speert H. Endometrial cancer and hepatic cirrhosis. Cancer. 1949; 2:597–603.PubMedCrossRefGoogle Scholar
  36. 36.
    Apperly FL. Endometrial hyperplasia in elderly women with hepatic cirrhosis. Va Med Monthly. 1951; 78:602.Google Scholar
  37. 37.
    Gordon GG, Olivo J, Rafii F, et al. Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endocrinol Metab. 1975; 40:1018–1026.PubMedCrossRefGoogle Scholar
  38. 38.
    Edman CD, MacDonald PC, Combes B. Ex-traglandular production of estrogen in subjects with liver disease. Gastroenterology. 1975; 69:819.Google Scholar
  39. 39.
    Rivarola MA, Singleton RT, Mignon CJ. Splanchnic extraction and interconversion of testosterone and androstenedione in man. J Clin Invest. 1967; 46:2096–2100.CrossRefGoogle Scholar
  40. 40.
    Edman CD, MacDonald PC. Extraglandular aromatization—primarily an extrahepatic metabolic process. Gynecol Invest. 1977; 8:50.Google Scholar
  41. 41.
    Edman CD, MacDonald PC. The role of extraglandular estrogen in women in health and disease. In: James VHT, Serio M, Gusti, G, eds. The endocrine function of the human ovary. London: Academic Press, 1976:135–140.Google Scholar
  42. 42.
    Southern AL, Olivo J, Gordon GG, et al. The conversion of androgens to estrogens in hyper-thyroidism. J Clin Endocrinol Metab. 1974; 38:207–214.CrossRefGoogle Scholar
  43. 43.
    Hemsell DL, Edman CD, Marks JF, et al. Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J Clin Invest. 1977; 60:455–464.PubMedCrossRefGoogle Scholar
  44. 44.
    MacDonald PC. Determinants of the rate of estrogen formation in postmenopausal women. Eur J Obstet Gynaecol Reprod Biol. 1979; 9/3:187–189.Google Scholar
  45. 45.
    Silverberg SG. Brenner tumor of the ovary. A clinical study of 60 tumors in 54 women. Cancer. 1971; 28:588–596.Google Scholar
  46. 46.
    Wren BG, Frampton J. Oestrogenic activity associated with nonfeminizing ovarian tumors after the menopause. Br Med J. 1963; 2:842–844.PubMedCrossRefGoogle Scholar
  47. 47.
    Wilkinson EJ, Friedrich EG, Mattingly RF. Turner’s syndrome with endometrial adenocar-cinoma and stilbestrol therapy. Obstet Gynecol. 1973; 42:193–200.PubMedGoogle Scholar
  48. 48.
    Cutler BS, Forbes AP, Ingersoll FM, et al. Endometrial carcinoma after stilbestrol therapy. N Engl J Med. 1972; 287:628–631.PubMedCrossRefGoogle Scholar
  49. 49.
    Dewhurst CJ, deKoos EB, Haines RM. Replacement hormone therapy in gonadal dysgenesis. Br J Obstet Gynaecol. 1975; 82:412–416.PubMedCrossRefGoogle Scholar
  50. 50.
    McCarroll AM, Montgomery DAD, Harley JMG, et al. Endometrial carcinoma after cyclical oestrogen-progestogen therapy for Turner’s syndrome. Br J Obstet Gynaecol. 1975; 82:421–425.PubMedCrossRefGoogle Scholar
  51. 51.
    Roberts G, Wells AL: Oestrogen-induced endometrial carcinoma in a patient with gonadal dysgenesis. Br J Obstet Gynaecol. 1975; 82:417–420.PubMedCrossRefGoogle Scholar
  52. 52.
    Sirota DK, Marinoff SC. Endometrial carcinoma in Turner’s syndrome following prolonged treatment with diethylstilbestrol. Mt Sinai J Med. 1975; 42:586–590.PubMedGoogle Scholar
  53. 53.
    Silverberg SG, Makowski EL. Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol. 1975; 46:503–506.PubMedGoogle Scholar
  54. 54.
    Fechner RE, Kaufman RH. Endometrial ade-nocarcinoma in Stein-Leventhal syndrome. Cancer. 1974; 24:444–452.CrossRefGoogle Scholar
  55. 55.
    Jackson RL, Dockerty MB. The Stein-Leventhal syndrome: Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol. 1957; 73:161–173.PubMedGoogle Scholar
  56. 56.
    Edman CD, MacDonald PC. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol. 1978; 130:456–461.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1983

Authors and Affiliations

  • M. Linette Casey
  • Paul C. MacDonald

There are no affiliations available

Personalised recommendations